Earnings Labs

Kustom Entertainment, Inc. (KUST)

Q3 2017 Earnings Call· Wed, Nov 15, 2017

$3.65

-4.45%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+0.00%

1 Week

+10.87%

1 Month

+21.74%

vs S&P

+17.15%

Transcript

Operator

Operator

Good morning and welcome to the Digital Ally third quarter 2017 operating results conference call. All participants will be in a listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. Statements made on today's call will include forward-looking statements including statements regarding our expectations, beliefs, intentions or strategies regarding the future including statements around projected spending. We intend that such forward-looking statements be subject to the Safe Harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking statements information is based on current information and expectations regarding Digital Ally Incorporated. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance and involve risks and uncertainties and assumptions that are difficult to predict. All forward-looking statements that are made on today's call are subject to risks and uncertainties that could cause our actual results to differ materially. These risks are discussed in our press releases we issued Tuesday evening and in greater detail in our Form 10-Q filed with the SEC under the caption Risk Factors. You may find this and our SEC filings on our website at www.digitalallyinc.com. Please note that this event is being recorded. I would now like to turn the conference over to Stan Ross, CEO of Digital Ally, Inc. and Tom Heckman, CFO of Digital Ally, Inc. Please go ahead.

Stan Ross

Analyst

Good morning everybody. Thanks for joining us today. We have quite a few areas to cover. I am going to touch on in the very beginning here our recent supply agreement that we signed with VieVU, which is a division of Safariland that I would like to elaborate a little bit on so you guys understand the significance of that. Also, we will talk about the reasoning that we retained ROTH Capital Partners to explore some strategic opportunities for us and how that came about. I will also give you an update on the litigation front and patent front as far as timing and elaborate on anticipated timing as well on when we expect to hear some rulings. And then Tom, I will it turn over to him so that he can handle the third quarter numbers. But let me start off with just saying that while I am excited about touching on these big events that have occurred for us since the last time we have talked, I do anticipate the news and the things that are going to be coming out of the Digital Ally camp between now and the next time we talk, which would be at the point where we would be a announcing our year-end numbers, to probably be one of the most active times that we will see. And that has a lot to do with stuff that's occurred, such as our supply agreement with VieVU. This is an agreement that we entered into after we were confident of the patent ruling that we received on the 452 patent, and we are very, very excited to partner up with these guys. They are very large. You may recognize VieVU as the ones that got the New York City contract. They recognize, and a matter…

Tom Heckman

Analyst

Sure. Thank you Stan and welcome everyone. I appreciate you us this morning. I would like to remind you that we did file our Form 10-Q yesterday evening and it is a full discussion of the events of the third quarter and year-to-date and I encourage you to go ahead and look through that for a full discussion. I will be hitting some of the highlights here and discussing some of the major issues or events that occurred to us in the third quarter that I think would be appropriate to discuss. First of all, I guess the third quarter was a difficult quarter for us, no doubt about it. I think it was really overshadowed by four substantial matters or issues that affected not only the third quarter, but in my opinion will dictate the fourth quarter and potentially even 2018 where the company has and that the benefits of resolving these issues. These four issues, I am not going to more detail about each one of these, but the first one is really the AMR contract and the halt in shipments that occurred in the second quarter. that affected the third quarter. The patent litigation which Stan has already discussed a little bit and really my comments on is more towards the high litigation and legal cost that we are incurring. Third is the market disruption that Axon has created because of their one-year free giveaway campaign. I want to talk about the impact of that to our quarter and how we plan on dealing with that on a go forward basis. And then fourth, I think the monetization of our VuLink patent, how it's our strategy to do that and how successful we are with that will be a major contributor to our fourth quarter as well…

Stan Ross

Analyst

Yes. Thanks Tom. Some of the things that we have done, I probably want to touch on them, but even some of the things that we talked about as far as being able to move some of the heavier lifting for some of the manufacturing to re-qualify manufacturers that are here in the Midwest. We are looking at probably a reduction of SG&A expense of right about $3.5 million for 2018. So that will be a dramatic improvement that should help us as far as the 2018 and going forward there. So all right, let's go ahead and open this up for Q&A.

Operator

Operator

[Operator Instructions]. Your first question comes from the line of Brian Kinstlinger with Maxim.

Brian Kinstlinger

Analyst

Great. Thanks. My first question, you addressed that cost side of the business, but given where cash is, at the end of your press release you announced potentially raising more funds. So maybe just talk about that as your cash balance is quite low, and I don't assume you will be generating cash flow in the next couple of quarters?

Stan Ross

Analyst

Brian, are you talking about talking about in the press release in regards to ROTH Capital Partners?

Brian Kinstlinger

Analyst

Yes. And I think even at the end of the -- that one was one for sure. I think maybe even at the end of last night's press release, you may have said something similar. So I am just curious, plans of financing operations? Why are those two the alternatives and burn a little bit of money at the same time?

Stan Ross

Analyst

Got you. So again, we have been approached by numerous parties that have wanted to get involved in maybe assisting in capital, in capital such as that's needed to assist with litigation and other matters. So again right now, what we are doing is just continuing to keep blinders on and trying to do what we can do to improve the underlying business. And we will wait and see what ROTH comes back with and what options that they think we have to look at and explore.

Brian Kinstlinger

Analyst

Then I think you talked, Stan, in the past in April when it was first announced, Axon's move to 1-year free, it wouldn't have a big impact on sales because they were already essentially giving away body cameras in lieu of the recurring subscription. And I think you had mentioned also, you were moving a little bit away from law enforcement. So as you guys mentioned, this is a disappointment in 3Q, can you touch on the impacts? So maybe let’s take a look at what first quarter revenues from body cameras as a percentage were and second quarter’s and what's changed that made you think it's having more of an impact than maybe you originally would have thought?

Tom Heckman

Analyst

Well, the percentage of revenue year-over-year went from 22%, down to 12%. So we lost almost half of the overall revenue mix year-over-year, and it's been a steady decline since they announced this one-year free giveaway, if you will. But again, that's the U.S. domestic market, law enforcement market. We are focusing more on the international law market and the domestic commercial or other uses of our body cameras, especially given the back office tailoring that we can do for specific industries, a la the cruise ship industry. We have also got several other products for specific uses in the mix that utilizes our FirstVu. So we are moving away from the domestic U.S. market as our primary source for FirstVu sales, body camera sales, and more into the domestic commercial marketing.

Stan Ross

Analyst

Yes. Brian, to give you an example, like obviously AMR was a great start for us with in-car systems, but you know there is clearly incidences and needs for what paramedics are doing outside of the vehicles when they are going into different locations and stuff like that, so we see the potential market there as well. And as I think we mentioned on the last call, while AMR was a great contract, we do have some unique pilots and other projects going on that are comparable or larger in size. So as I have stated in the past, we do see and do believe that our commercial division has a real shot of surpassing law enforcement in 2018.

Brian Kinstlinger

Analyst

So just to be clear, the 12% of revenue, is that U.S. sales of body cameras? Or is that total sales of body cameras?

Stan Ross

Analyst

That's 12% of our total revenues.

Brian Kinstlinger

Analyst

Total body cameras. So what was that number in the first quarter and the second quarter of this year?

Tom Heckman

Analyst

I don't have that specifically in front of me, but it's been a steady decline since they’ve done that.

Brian Kinstlinger

Analyst

But that's my point. Is year-over-year is necessarily a view, I mean I am curious. Did it start happening in April or was the first quarter already off to a low start?

Stan Ross

Analyst

Well, I think you could tie some of it back to when the stay was announced, because again it continued to allow the industry to go out there and our competitors to go out there and state that, oh, you know, Digital Ally's patent isn't going to stand up, it doesn't have any meat to it. And so, I think that's really when we started seeing it, let alone part of their campaign. So it did start a little bit in the late first quarter of last year – or this year.

Brian Kinstlinger

Analyst

Okay. Can you comment on the price the VieVU is paying for each device? I mean, you mentioned the word huge twice. But even if I assume $100 per device, that's $1 million next year. So maybe that $100 price tag is way too low. But I am just trying to understand what this contribution might be for 10,000 devices?

Stan Ross

Analyst

So let me state it this way. We retail that out at $495, okay. Obviously, the quantities that they are buying, we greatly discounted that to them.

Brian Kinstlinger

Analyst

Okay. And then if you could take us through the thought process of giving an exclusive to VieVU, you mentioned in monetizing the patents potentially licensing it to others. But how would that work given VieVU has an exclusive agreement?

Stan Ross

Analyst

So what we are looking at is, is they have got an exclusive agreement when it pertains to the law enforcement side of things, okay. And if you are looking at the fact that it's 10,000 units and we start saying, okay, well, it's a pretty good number, but on top of that if we were able to maybe get 20%, 30% of our in-car systems associated with that number, it becomes a really big number. And again they are very large. I mean if you just look at the fact that they got the New York contract, that could be 40,000 to 50,000 units just right there as far as body camera. And most likely, they are going to be an auto activation device associated with every one of those body cameras.

Tom Heckman

Analyst

Yes. Just as a matter background, VieVU as it sits today does not offer an in-car system. So we are hopeful that with them offering our VuLink with their body camera, a natural is for them to package our in-car systems with that offering. And quite often, RFPs come out as packages that include both body cameras and in-car systems. And you couple that with the fact that VieVU is owned by Safariland and I understand not a lot of people know who Safariland is, but they are huge. My understanding is that they are $2 billion.

Stan Ross

Analyst

Two-and-a-half times size TASER is my understanding.

Tom Heckman

Analyst

Yes. They have a heavy presence in military and they have an international worldwide selling organization. So that's really the allure of looking at VieVU. They are obviously a very well-backed company financially and managerially being part of Safariland. They need in-car systems to compete for package contracts and then have an enormous worldwide sales organization, not only in an law enforcement but military and also commercial. So it was a natural fit for us that we thought made a lot of sense.

Brian Kinstlinger

Analyst

Okay. Last question I have got is, can you talk about the price paid for COBAN and what their annual revenue is so we see the valuation that they --

Stan Ross

Analyst

Yes. Brian. I tried to get that out of them. They would not give me that number. I tried. But yes, sorry.

Brian Kinstlinger

Analyst

Okay. Thanks.

Stan Ross

Analyst

Thank you Brian.

Operator

Operator

Your next question comes from the line of Ishfaque Faruk with WestPark Capital.

Ishfaque Faruk

Analyst · WestPark Capital.

Hi. Good morning Stan and Tom.

Stan Ross

Analyst · WestPark Capital.

Good morning Ish.

Ishfaque Faruk

Analyst · WestPark Capital.

Okay. In terms of contract with VieVU, in the previous quarter you mentioned the price per unit and you gave a little bit of color. Is it going to be based on a price per unit? Or is it going to be based on a percentage of sales? What are the economics in terms of the contract needs?

Stan Ross

Analyst · WestPark Capital.

It's clearly based upon units. They have to acquire 10,000 units.

Ishfaque Faruk

Analyst · WestPark Capital.

And you mentioned that you are greatly discounting that. So is it like 20%, 30%, 40% discount to your current retail price? Or what's the --

Stan Ross

Analyst · WestPark Capital.

Yes. I sure can hear you go. With all that said, we normally on single sale in a single unit, we retail it at $495. And we needed to discount it greatly so that they can put it in their mix, have a little wiggle room themselves to recover and make a little money. At the same time, really be in a position to sell the body cameras as well. So that's all I can really tell you at this point.

Ishfaque Faruk

Analyst · WestPark Capital.

Okay. Well, in terms of your preliminary conversations with your M&A advisor, do you have a sense for which direction you guys are leading towards?

Stan Ross

Analyst · WestPark Capital.

We do not. What I did is, a couple of the people that had contacted me, I shared with them and these are parties that there are already familiar with because they were part of the interest and process, let's say, that looked at COBAN. Since then and knowing what's going on and the timing, which the timings getting mirrored in regards to potential things that could be occurring on the litigation front, I think that is what really started sparking things to get moving. So what I have done is try to stay out of it at this point until there has been enough time for it to run its course. Like I said, we only retained them back November 8. So it has -- what are we looking at? Just over a week almost, about a week. So anyway, all the ones that have contact me directly, I have forwarded out to ROTH and I am sure we will have an update almost weekly on what's going on and what they are asking of us.

Ishfaque Faruk

Analyst · WestPark Capital.

Okay. What's your current your near term view on your litigation? Do you have some sense on where you could get something more conclusive? Because it has been running, it has been getting stretched for like almost a year now, right?

Stan Ross

Analyst · WestPark Capital.

Yes. I mean, correct. I mean, I think the last stay got put in place in March of this year. And the Patent Office came back and ruled in our favor. We have obviously got back in front of the courts. We both submitted our paperwork. And so I am anticipating that we are real close because I know the courts now, they didn't give us much of a timeline. They said, you get 10 days and 10 pages and then you have got 10 days and 10 pages for rebuttal. And so that was a rather quick turn that they are requesting of us. So I would hope that and as we requested for this to be expedited that is what's happening and they are going to look at it and rule to move forward rather quickly. We have already said, hey, we will pull the 292 out of that. We won't even consider the damages on the 292. And so it makes it a lot simpler and clear for the courts to just evaluate the 452 patent. So yes, I mean it could happen today. I just don't know. But it's been 30 days and I would hope something rather quickly.

Ishfaque Faruk

Analyst · WestPark Capital.

Okay. In terms of the AMR contract, so you guys are still not up and running for that contract as of yet. But are you guys going to be, like you know in Q4, I do think that contract will start generating revenue again?

Tom Heckman

Analyst · WestPark Capital.

Well, this is Tom. I will tell you that this is a very fluid situation and up until about a week or so ago, I really expected that we would have to go to court to enforce the PO's that are outstanding. But there has been a lot of dialogue, a lot of constructive dialogue in the last seven to 10 days that encourage me that we can get this resolved amicably between the parties and that we can restart at least a portion of the contract in the fourth quarter. Now that being said, it takes two parties to agree and move forward. We certainly don't have that affirmative answer yet but the dialogue is very encouraging. Or at least the recent dialogue is very encouraging that they understand the importance of video in their ambulances and what we provide and we can get the thing going. Just as a side, we have had a six-year relationship or seven-year relationship with AMR and like I said, we recorded over 1.3 million videos of incidences and just last week there was a major collision with one of the ambulances that our system caught perfectly. So you know, it's unfortunate what happened out in Jupiter, Florida. We don't know what the cause of it was or what the real reason for the unit not to have recorded that incident. But I think they are looking at the larger picture. We are looking at the larger picture as well. And admit that willing parties can get to a real resolution.

Stan Ross

Analyst · WestPark Capital.

Yes. It's Stan again. We could be speculating a little bit here but obviously they know that this unit is not a black box like it hitting an airplane and that particular incident was a very violent crash. But with the hurricanes, with their acquisition, there are probably a lot of moving parts for the delay but we have had a great relationship. We look to try to continue that relationship. And what Tom said, there is real fluid dialogue going on right now.

Ishfaque Faruk

Analyst · WestPark Capital.

All right. Thank you guys.

Stan Ross

Analyst · WestPark Capital.

Thank you.

Operator

Operator

Your next question comes from the line of Patrick McEvoy.

Patrick McEvoy

Analyst

Yes. Hello.

Stan Ross

Analyst

Hi Patrick.

Patrick McEvoy

Analyst

Hi. How are you doing today?

Stan Ross

Analyst

Doing real good. Yourself?

Patrick McEvoy

Analyst

Yes, not bad. I just have two quick questions. One is, I don't know as though I heard anything from you guys in a while about the utility stuff. And if there was ever a resolution to what was going on with them?

Stan Ross

Analyst

Utility, the litigation?

Patrick McEvoy

Analyst

Right.

Stan Ross

Analyst

I have seen something just the other day, I don't know if I can talk about the timing.

Tom Heckman

Analyst

Yes. We have appealed that ruling from the federal district court judge and the oral arguments on that appeal is sometime in January 2018. So I want to say the 16th, but that may or may not be right. But the hearing, the appeal hearing is coming very, very soon in calendar year 2018.

Patrick McEvoy

Analyst

Okay. So it is still an ongoing process.

Stan Ross

Analyst

Correct.

Tom Heckman

Analyst

Yes.

Patrick McEvoy

Analyst

Right. Okay. My other question is, Axon just announced like a week ago that they finally are installing their in-car fleet video systems and the press release mentions Fort Worth and Louisiana and New Orleans and that specifically mentions Axon's signal technology as well in the press release. Do you guys think this is going to have any major effect on the in-car stuff that you guys are --?

Stan Ross

Analyst

This is exactly why we are so frustrated. We have got a technology. We own a patent. We have got a patent that's been challenged in the Patent Office numerous times and we have been successful in defending it. And now we are just waiting on the courts to allow us the ability to, I guess, stand behind them. The majority of our new designs are going to be and are utilizing this patented technology. And until the courts, I hate to say it, wake up and address this, TASER and WatchGuard is just going to try to walk all over us. So then hope they get their hands slapped, in the meanwhile they have drummed up enough business that it doesn't hurt too bad. So we will make sure and do a masterful job of explaining the damages that have occurred and the damages that will be going forward because these contracts, most of them are like five years, but hate to say that, if someone has already got five years worth of video, they are probably going to go to another five years. So it's not just short term damages. So we will be pushing for a big number.

Patrick McEvoy

Analyst

Does that mean that you could maybe push to say that you get an ongoing revenue from the contract that they have that were made before winning the litigation?

Stan Ross

Analyst

Exactly. So absolutely.

Tom Heckman

Analyst

Yes. Patrick, the question of willful infringement, I think has already been answered. We know that they are willfully infringing and if that's found, whatever actual damages are generally trebled can be trebled in the award. So yes, I mean it's unfortunate that we have got to defend our patent to the Nth degree and allow this to occur. But we are powerless until the court acts. And we believe that the court will act soon and in our favor. And when that happens, I think the course has been set.

Patrick McEvoy

Analyst

Right. Okay. Thank you.

Stan Ross

Analyst

Thank you.

Operator

Operator

Your next question comes from the line of Ira Thomas.

Ira Thomas

Analyst

Hello.

Stan Ross

Analyst

Hi Ira.

Ira Thomas

Analyst

Hi. How are you doing? You know, I am a long time investor. I was buying this three-plus years ago when the stock was moving up to $15 and $20 and buying it and hey, I may sound like I am an antagonist, but my voicing question is the last sure thing, I want obviously, I like stock at $15. But ever since I started listening to the calls, this is probably the 12th quarter in a row, it's like a tape recorder. It's everyone, same thing, we missed our predictions. We missed their sales thing in this. And I said to you three years ago, it's the only other time they took one of my calls, this is only the second time, even though I have listened to everyone and tried to get in. I told you that I was a litigator and I said to you, hey, it's nice as a, I am trying to think of superfluous, whatever an extra, an aside money from patents. But I told you my experience is, hey, let's not base the company on our host of patents. Let's worry about sales. And always heard cream rises to the top and this company has always touted itself as having the best product. So I go, I can tell other people and friends, buy this stock, they got the best product. I am taken to understand to worry but I also worry for what it is. And I listened to this for three years about TASER and Axon and what you are doing with the other company, if we have got the best product, why have the sales for 12, 13 straight quarters just continued to just like go away like nonexistent almost. What's out there and I hear the fact that again I have never understood the reason every quarter talking about the confusion, that shouldn't stop somebody from buying our product. It should stop them from buying someone else's because certainly the other companies are not claiming they have got the patent. They are just claiming that we don't have a patent that they can sell theirs. I have never understood how that's affecting our ability to sell the Digital Ally product, because there is confusion whether there is patent or not. Again, if our products are best, why haven't the salesman been able to sell this for the last three years?

Stan Ross

Analyst

Yes. There is a couple of ways to address that. One is, as you know earlier on, we got into a situation with TASER and it's very, very well documented in regards to the amount of police officers that have bid on their payroll or contributions or things along those lines that it just doesn't make sense. We have had situations where our sales reps would come back and say, they are just frustrated, TASER got the contract. Why did they get the contact? Don't know? But the chief loved it, the chief loved it, everyone said they loved it. We are moving forward on it. I absolutely felt we had it. And then all of a sudden from up above or from another angle, they decide to go with TASER and I can also show you where there are municipalities out there and you can do your own homework and see that there is a lot of complaints that have been out there by local departments and other, I want to say, people that didn't looking into the fairness of how some of the contracts were awarded. And so going from there, I give you an example where we had a bit of right at a little over $600,000 on a particular bid and TASER comes in that $1.4 million and it just doesn't make any sense. But some of the things that TASER is capable of doing that we are not at this point is they are throwing other items into the mix. You know they are throwing in some of their TASERs and their cartridges other things trying to, again look at their numbers. They are buying the business and hoping that at the end of the day that they get enough people signed up, their hand gets barely slapped that this strategy worked for them. So we still feel very, very confident we have got a very solid product. We provide a five-year warranty on the product, we are so confident in it. The specs with our product are very high quality to where we have got to be one of the leaders in the industry as far as the quality of product. So it has to just to be some of the, I don't know, I won't call it strong arming, but some of the things just don't make any financial sense at all why they went some of the routes with some of these department.

Operator

Operator

Your next question comes from the line of Bryan Lubitz of Aegis Capital.

Bryan Lubitz

Analyst

Good morning guys.

Stan Ross

Analyst

Good morning Bryan.

Bryan Lubitz

Analyst

In regards to the 10,000 body cameras for Safariland, is that the largest contract you guys have ever had for body cameras?

Stan Ross

Analyst

Well, this is for the viewing. It is certainly the largest for viewing.

Tom Heckman

Analyst

Yes. Certainly for viewing, for sure.

Bryan Lubitz

Analyst

Okay. So when you say you retail it at $495, but obviously you guys discounted it heavily. It's not like we gave it away for free, like what TASER is doing. Can you give me an idea of what the retail is for the entire system, the in-car dash, the VuLink, the body cameras, the works?

Stan Ross

Analyst

So it would depend a little bit on which in-car system that you went with. But you know, we can set in their pack each a body camera, a nice in-car system like or DVM 800 and also the VuLink product. It can come in, depending on quantities, anywhere from, if the quantities are large, we can get down to around $4,000 and they will have a complete system with all the everything that they would need. But smaller quantities, they could see it as high as $4,700.

Bryan Lubitz

Analyst

So between $4,000 and $4700. And typically when you package that together, what are your gross margins? Are you guys at 40%? Do you have 50%?

Stan Ross

Analyst

A package like that, we would hit 60%.

Bryan Lubitz

Analyst

60%. Okay. And then obviously that's before heavily discounting it. So where I am going is, if you guys have signed up with Safariland and you have this exclusive contract, yet they don't have that other part in their array to sell, you guys feel confident that that's something that could be a potential moving forward.

Stan Ross

Analyst

Yes, absolutely. I mean these guys have been great to work with. They approached us over a year ago inquiring about our VuLink and our VuLink technology. And I don't know if I have ever told you this or said it on a call, but one of the principles there at VieVU, his wife is a patent attorney and they looked into it and they felt that it had a lot of strength behind it. And therefore they decided not to try to walk all over and run the risk like TASER and WatchGuard are doing.

Bryan Lubitz

Analyst

Okay. So now in regards to the 10,000 units per year, your press release also states that it will be increasing each year. Is that based upon how they do in the first year? Or is that something that's already been put down in a contract? Do we know what that is going to be that increase?

Tom Heckman

Analyst

Yes. We know what the increase is. It's a dollar amount.

Bryan Lubitz

Analyst

In terms of the amount of units, does that increase or just the dollar amount we take home?

Tom Heckman

Analyst

Dollar amount we take home.

Bryan Lubitz

Analyst

Okay. Now in regards to obviously the litigation with TASER. This case, if you make it that from the first day they put out a press release stating that you guys had your patents invalidated, that they have been working on infringing from that point, am I right, have they sold about $240 million worth of revenue on these body cameras they are giving free?

Stan Ross

Analyst

Tom studied the numbers more than I but they claim to have booked over $600 million in potential business.

Bryan Lubitz

Analyst

Maybe even more.

Stan Ross

Analyst

Yes.

Bryan Lubitz

Analyst

Okay.

Tom Heckman

Analyst

And remember Bryan that this thing was all started after we got our patent issued in, I think it was, 2014. Later that year, they came out and filed an IPR challenge against that patent. So it wouldn't be just from the time that we sued him or anything. It would be all we back to then that they knew they were willfully infringing because they tried to invalidate it back then. So yes. And that $600 million figure is their total of bookings, they call it, which is the total length of the contract, the hardware cost, the service cost that they are charging and that was, I think, in the last quarter. I am sure it's maybe $100 million more now.

Stan Ross

Analyst

And I think I said this before on the call that when they look at the way they look at damages, they look at the all encompasses of a package. So in other words, if they won a $5 million package and auto activation that was part of that or the potential upgrade to that was part of it, then that whole $5 million that gets looked at as far as damages.

Bryan Lubitz

Analyst

Well, okay. So that being said, as you guys know I have been on these calls for a long time. I know I was upset and I know Maxim and WestPark may be a little upset because they didn't get the deal ROTH got. That being said, $600 million and I am trying to help them in asking for the revenue and the damages, et cetera., $600 million, let's say your average royalty contract in the electronic space is 20%. Let's just call it for what it is, let's go even more conservative and say 10%. You guys are looking at before treble damages of roughly $60 million, if they were to compute it that way in terms of potential damages TASERs way before treble damages. Does that sound right?

Tom Heckman

Analyst

You ran your numbers correctly. And I would sit there and say that in the industry, it can easily be as high as 35%.

Bryan Lubitz

Analyst

Okay.

Tom Heckman

Analyst

So the number is all over the board.

Bryan Lubitz

Analyst

I don't want to step on you. But I also want to make sure that I don't get cut off from the operator. So those numbers, well, whatever it be, it is roughly four times your market cap of where you are on a very conservative basis. Now, WatchGuard just filed for an IPO. And am I right in assuming that when they released their revenues, they did a lot more in revenue than we had expected?

Stan Ross

Analyst

Yes. They have built quite a little company. So like you said, this year they are on a run rate of somewhere around $90 million to maybe $100 million. And I think last year, they showed on their books, I think it was right at $70 million. So again, there you go back to just start adding up there. And that's what they are showing as revenue. That's not showing or talking about what they may have booked in ongoing services.

Bryan Lubitz

Analyst

So Stan, you are looking at what? Over $100 million in damages before treble damages? And just for everyone that doesn't know what treble damage is, it's three times the damage amount, correct?

Stan Ross

Analyst

It's a big number, Bryan.

Bryan Lubitz

Analyst

All right. So that being said and this would be my last question. Obviously, a bunch of guys or companies were in on the COBAN deal that didn't get what they were looking for at outbid, whatever and a handful of them or however many of them are contacting Digital for potential buyout or exploring strategic opportunities. Taking into account that you have potentially $100 million in money minimum coming your way, I think you are tracking a lot more, do you guys have a number in mind that you are thinking about? Will you guys, if they are bidding for you, that you drop that number that you would look for if they were to come knocking?

Stan Ross

Analyst

Yes. We haven't discussed. It's just too early. We haven't discussed anything along those lines and haven't gotten any feedback from ROTH yet on what everyone's thinking yet.

Bryan Lubitz

Analyst

Yes. It's has only been a week.

Stan Ross

Analyst

Obviously.

Bryan Lubitz

Analyst

All right. Well, listen, good luck to you guys. I hope everything works out with ROTH and we will be eagerly awaiting the results

Stan Ross

Analyst

Thanks Bryan.

Bryan Lubitz

Analyst

Thank you.

Operator

Operator

There are currently no further questions in queue. I will turn the call back over to presenters for closing remarks.

Stan Ross

Analyst

Well, again, thanks everybody for your time this morning and again we are very excited about what's going to be taking place over the next, let's call it, 120 days before we have our next call unless obviously a settlement of major material develops, we would probably reschedule something. But just keep watching. As soon as we learn status of things, we will make sure and let everyone know. And again, we will continue to be out there working very hard for you all. So thank you.

Operator

Operator

Again, thank you for your participation. This conclude today's call. You may now disconnect.